sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a disclosure form under Rule 8.3 of the Irish Takeover Panel Act of 1997. This disclosure relates to its interests in Mural Oncology plc. As of September 25, 2025, Vanguard owns or controls 646,504 ordinary shares, representing a 3.74% stake in Mural Oncology.
The form indicates Vanguard's recent dealings in Mural Oncology securities, including a purchase of 16 shares at $2.09 per unit and a sale of 48 shares at the same price. No cash-settled or stock-settled derivatives have been reported in this disclosure.
Vanguard has clarified that no indemnity or option arrangements are in place regarding Mural Oncology's securities. Furthermore, there are no agreements related to voting rights or future transactions of the mentioned securities.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.